M2M Med.sp. z o.o.
Other research and experimental development on natural sciences and engineering
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2019-01-22
Share capital
5,000.00 PLN
Registered address
ul. Lwowska 34, 41-500 Chorzów, Poland
Financials
Revenue history (in k)
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 92 days for 2021).
- 202502/07/2026
- 202427/06/2025
- 202316/07/2024
- 202231/03/2023
- 202115/10/2022
- 202018/10/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 353.54MedianUSD 73.26kAverageUSD 3.23m
Net profit
This companyUSD -10.28kMedianUSD 68.58AverageUSD 82.17k
Operating costs
This companyUSD 9.90kMedianUSD 75.78kAverageUSD 3.04m
Assets
This companyUSD 50.54kMedianUSD 119.88kAverageUSD 3.90m
Industry
Authorized Representatives
Agata Justyna Ibrom – Attorney-in-fact (sole)
Wojciech Roman Pacuła – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Monika Danuta Pacułaage 37 | 91 | $1,229.07 | 91% |
Others | 9 | $121.56 | 9% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
M2M Med. Badaniasp. z o.o. | 1,350.62 USD | 33.3333% |
Bank accounts
Registered as a VAT taxpayer on 2019-03-20.
No bank accounts reported to the VAT Taxpayer Register.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $20,189.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $559$559 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $18,462$18,462 | Polski Fundusz Rozwoju S.A. | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $596$596 | Prezes Zakładu Ubezpieczeń Społecznych |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| XORsp. z o.o. | $106,820.82 | x-or.pl | ||
| Abrahamsp. z o.o. | $101,047.98 | abraham.eco | ||
| Clinical Medical Research IIsp. z o.o. | $62,821.47 | clinicalmedicalresearch.pl | ||
| Greenbacksp. z o.o. | $58,025.69 | greenback.net.pl | ||
| Centrum Transferu Technologii Groupsp. z o.o. | $55,751.51 | cttgroup.pl | ||
| Medaisp. z o.o. | $22,311.83 | medai.pl | ||
| Novelty Hub TechnologicznyP.S.A. | $12,970.87 | noveltyhub.pl | ||
| HAPE Polskasp. z o.o. | $11,444.94 | hape-heatpumps.eu | ||
| AI4Isp. z o.o. | $8,770.79 | ai4i.pl | ||
| Magowiesp. z o.o. | $154.10 | magowie.pl |
Change history
| Date | Event | |
|---|---|---|
| 2022-06-22 | Name change (M2m Badania Kliniczne → M2m Med.) | |
| 2022-06-22 | PKD change (Removed: 86.10.Z; Added: 85.59.B) | |
| 2019-12-12 | PKD change (Removed: 86.23.Z; Added: 68.20.Z) | |
| 2019-04-05 | Address change (Ul. Ligocka 103, 40-568, Katowice → Ul. Lwowska 34, 41-500, Chorzów) | |
| 2019-01-22 | Entered in the register |
FAQ
The main business activity of M2M Med. focuses on other research and experimental development on natural sciences and engineering.
The company was registered in the Polish National Court Register (KRS) on January 22, 2019.
The headquarters is located at: ul. Lwowska 34, 41-500 Chorzów.
The management board includes Wojciech Roman Pacuła (President of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company generated total revenue of $26,618, representing an increase of 453.0% compared to 2023.
Yes, in 2024 the company achieved a net profit of $11,922.
The largest operating cost category falls under external services. This category amounted to $8,053 in 2024, representing 62% of all operating expenses.
Last updated: 2026-07-02